IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,865,000 | -1.4% | 3,789,000 | 0.0% | 0.05% | +64.3% |
| Q4 2021 | $3,919,000 | -5.2% | 3,789,000 | 0.0% | 0.03% | -22.2% |
| Q3 2021 | $4,132,000 | -4.0% | 3,789,000 | -3.9% | 0.04% | -7.7% |
| Q2 2021 | $4,304,000 | +12.1% | 3,942,000 | +10.6% | 0.04% | -9.3% |
| Q1 2021 | $3,841,000 | -20.3% | 3,565,000 | -19.9% | 0.04% | +2.4% |
| Q4 2020 | $4,819,000 | +287.7% | 4,453,000 | +272.3% | 0.04% | +68.0% |
| Q3 2020 | $1,243,000 | -1.2% | 1,196,000 | 0.0% | 0.02% | -39.0% |
| Q2 2020 | $1,258,000 | -1.0% | 1,196,000 | 0.0% | 0.04% | -18.0% |
| Q1 2020 | $1,271,000 | -9.5% | 1,196,000 | 0.0% | 0.05% | +92.3% |
| Q4 2019 | $1,404,000 | -92.5% | 1,196,000 | -93.1% | 0.03% | -95.0% |
| Q2 2019 | $18,669,000 | +51.8% | 17,430,000 | +56.5% | 0.52% | +9.6% |
| Q1 2019 | $12,301,000 | -7.5% | 11,136,000 | -21.3% | 0.48% | -49.7% |
| Q4 2018 | $13,295,000 | – | 14,145,000 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,953,000 | 0.83% |
| CSS LLC/IL | 10,119,000 | $11,031,000 | 0.46% |
| DeepCurrents Investment Group LLC | 13,556,000 | $14,917,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $11,014,000 | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,592,000 | $31,218,000 | 0.24% |
| HBK INVESTMENTS L P | 14,616,000 | $15,971,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,334,000 | 0.05% |
| Verition Fund Management LLC | 3,942,000 | $4,304,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 10,037,000 | $10,959,000 | 0.01% |
| Calamos Advisors LLC | 2,423,000 | $2,648,000 | 0.01% |